TWM
NVO

Tripletail Wealth Management’s Novo Nordisk NVO Stock Holding History

Tripletail Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.84K Sell
158
-11
-7% -$521 0.01% 224
2025
Q4 		$8.6K Sell
169
-27
-14% -$1.38K 0.01% 216
2025
Q3 		$11.6K Buy
+196
New +$11.5K 0.01% 251

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Tripletail Wealth Management's NVO Position: Q1 2026 in Review

Tripletail Wealth Management reduced its Novo Nordisk (NVO) stake by 6.5% in Q1 2026, selling an estimated $521 and leaving 158 shares worth $5.84K. The position accounts for 0.01% of the portfolio, ranked #224.

Tripletail Wealth Management first reported a position in NVO in Q3 2025 and has held it in 3 quarters since. The position peaked at $11.6K in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Tripletail Wealth Management held 158 shares of Novo Nordisk worth $5.84K as of Q1 2026.
  • Tripletail Wealth Management sold 11 Novo Nordisk shares in Q1 2026, an estimated $521.
  • Novo Nordisk made up 0.01% of Tripletail Wealth Management's portfolio in Q1 2026, its #224 holding.
  • Tripletail Wealth Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 3 quarters since.
  • Tripletail Wealth Management's Novo Nordisk position peaked at $11.6K in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Tripletail Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.